Preimplantation Genetic Testing for Aneuploidy (PGT-A)
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Clinical Whole Exome Sequencing (cWES)
Search
Prenatal Genetic Testing
Prenatal testing for genetic disorders is an invasive procedure that is performed during pregnancy
This test is done through either Chorionic Villus Sampling (CVS) at 9-14 weeks or Amniocentesis at 14-16 weeks.
The test will help to identify a chromosome abnormality or any other genetic disease in the fetus.
Prenatal Detection tests at Genalive can reveal a wide range of genetic diseases.
Early detection of genetic disorders and chromosomal abnormalities
Could prevent having abnormal baby with a known genetic disease
Provides confirmation for a pregnant woman who is having a baby where the fetus underwent PGT-M testing.
Detects many genetic diseases and chromosomal abnormalities
>97 % Depending on the mutation type
Family history of genetic disease.
Abnormal fetal structure identified with ultrasound.
Confirmation for a pregnant woman who is having a baby where the fetus underwent PGT-M testing.
Positive results from a prenatal screening test.
Turnaround times for specific tests vary as per the table below. TATs are calculated from the time the sample is received and accepted at the laboratory.
| Product Name | Product Code | TAT |
|---|---|---|
| Prenatal Genetic Testing for Known Mutation (Sanger+MCC) | SDX3301 | 20 days |
| Prenatal Genetic Testing for Unknown Mutation (BGI-Xome™ cWES) Trio | SDX3302 | 10-15 days |
Trio – Indicates that three samples need to be tested – mother, father, and fetus.
Genalive Genetic Counselors are available to Healthcare providers to help navigate which test is best for their patient
